APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-injectable GnRH Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-injectable GnRH Drugs Industry Growth and Trends Forecast to 2032

Report ID 174017580128 December 202593 pages

Choose your research edition.

Industry ResearchNon-injectable GnRH Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-injectable GnRH Drugs Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Non-injectable GnRH Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-injectable GnRH Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-injectable GnRH Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Non-injectable GnRH Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-injectable GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-injectable GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-injectable GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-injectable GnRH Drugs include Sanofi, Pfizer, Abbvie, Sumitomo Pharma, ObsEva, Neon Healthcare, JW Pharmaceutical, Fuji Pharma and ASKA Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-injectable GnRH Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-injectable GnRH Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-injectable GnRH Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-injectable GnRH Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non-injectable GnRH Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-injectable GnRH Drugs Market by Company

Sanofi

Pfizer

Abbvie

Sumitomo Pharma

ObsEva

Neon Healthcare

JW Pharmaceutical

Fuji Pharma

ASKA Pharmaceutical

Non-injectable GnRH Drugs Segment by Type

Tablets

Nasal Spray

Others

Non-injectable GnRH Drugs Segment by Application

Menorrhagia

Central Precocious Puberty

Uterine Fibroids

Endometriosis

Other

Non-injectable GnRH Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-injectable GnRH Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-injectable GnRH Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-injectable GnRH Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-injectable GnRH Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-injectable GnRH Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Nasal Spray Table 3. Major Company of Others Table 4. Global Non-injectable GnRH Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Non-injectable GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Non-injectable GnRH Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Non-injectable GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Non-injectable GnRH Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Non-injectable GnRH Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Non-injectable GnRH Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Non-injectable GnRH Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Non-injectable GnRH Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Non-injectable GnRH Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Non-injectable GnRH Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Non-injectable GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Non-injectable GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Non-injectable GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Non-injectable GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Non-injectable GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Non-injectable GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Non-injectable GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Non-injectable GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Non-injectable GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Non-injectable GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Non-injectable GnRH Drugs Industry Trends Table 26. Non-injectable GnRH Drugs Industry Drivers Table 27. Non-injectable GnRH Drugs Industry Opportunities and Challenges Table 28. Non-injectable GnRH Drugs Industry Restraints Table 29. Global Non-injectable GnRH Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Non-injectable GnRH Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Non-injectable GnRH Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Non-injectable GnRH Drugs Sales Share by Company (2021-2026) Table 33. Global Non-injectable GnRH Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Non-injectable GnRH Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Non-injectable GnRH Drugs Major Company Production Sites and Headquarters Table 36. Global Non-injectable GnRH Drugs Company, Product Type & Application Table 37. Global Non-injectable GnRH Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Non-injectable GnRH Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Non-injectable GnRH Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Non-injectable GnRH Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Non-injectable GnRH Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Non-injectable GnRH Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Non-injectable GnRH Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Non-injectable GnRH Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Non-injectable GnRH Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Non-injectable GnRH Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Non-injectable GnRH Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Non-injectable GnRH Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Non-injectable GnRH Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Non-injectable GnRH Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Non-injectable GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Non-injectable GnRH Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Non-injectable GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Non-injectable GnRH Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Non-injectable GnRH Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Non-injectable GnRH Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Non-injectable GnRH Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Non-injectable GnRH Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Non-injectable GnRH Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Non-injectable GnRH Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Non-injectable GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Non-injectable GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Non-injectable GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Non-injectable GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Non-injectable GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Non-injectable GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Non-injectable GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Non-injectable GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Non-injectable GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Non-injectable GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sanofi Non-injectable GnRH Drugs Product Portfolio Table 76. Sanofi Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Pfizer Non-injectable GnRH Drugs Product Portfolio Table 81. Pfizer Recent Development Table 82. Abbvie Company Information Table 83. Abbvie Business Overview Table 84. Abbvie Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Abbvie Non-injectable GnRH Drugs Product Portfolio Table 86. Abbvie Recent Development Table 87. Sumitomo Pharma Company Information Table 88. Sumitomo Pharma Business Overview Table 89. Sumitomo Pharma Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sumitomo Pharma Non-injectable GnRH Drugs Product Portfolio Table 91. Sumitomo Pharma Recent Development Table 92. ObsEva Company Information Table 93. ObsEva Business Overview Table 94. ObsEva Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. ObsEva Non-injectable GnRH Drugs Product Portfolio Table 96. ObsEva Recent Development Table 97. Neon Healthcare Company Information Table 98. Neon Healthcare Business Overview Table 99. Neon Healthcare Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Neon Healthcare Non-injectable GnRH Drugs Product Portfolio Table 101. Neon Healthcare Recent Development Table 102. JW Pharmaceutical Company Information Table 103. JW Pharmaceutical Business Overview Table 104. JW Pharmaceutical Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. JW Pharmaceutical Non-injectable GnRH Drugs Product Portfolio Table 106. JW Pharmaceutical Recent Development Table 107. Fuji Pharma Company Information Table 108. Fuji Pharma Business Overview Table 109. Fuji Pharma Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Fuji Pharma Non-injectable GnRH Drugs Product Portfolio Table 111. Fuji Pharma Recent Development Table 112. ASKA Pharmaceutical Company Information Table 113. ASKA Pharmaceutical Business Overview Table 114. ASKA Pharmaceutical Non-injectable GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. ASKA Pharmaceutical Non-injectable GnRH Drugs Product Portfolio Table 116. ASKA Pharmaceutical Recent Development Table 117. North America Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. North America Non-injectable GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 119. North America Non-injectable GnRH Drugs Sales Market Share by Country (2021-2026) Table 120. North America Non-injectable GnRH Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 121. North America Non-injectable GnRH Drugs Sales Market Share Forecast by Country (2027-2032) Table 122. North America Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Non-injectable GnRH Drugs Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Non-injectable GnRH Drugs Market Share by Country (2021-2026) Table 125. North America Non-injectable GnRH Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Non-injectable GnRH Drugs Market Share Forecast by Country (2027-2032) Table 127. Europe Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Europe Non-injectable GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 129. Europe Non-injectable GnRH Drugs Sales Market Share by Country (2021-2026) Table 130. Europe Non-injectable GnRH Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 131. Europe Non-injectable GnRH Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Non-injectable GnRH Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Non-injectable GnRH Drugs Market Share by Country (2021-2026) Table 135. Europe Non-injectable GnRH Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Non-injectable GnRH Drugs Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Non-injectable GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 139. Asia-Pacific Non-injectable GnRH Drugs Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Non-injectable GnRH Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 141. Asia-Pacific Non-injectable GnRH Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Non-injectable GnRH Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Non-injectable GnRH Drugs Market Share by Country (2021-2026) Table 145. Asia-Pacific Non-injectable GnRH Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Non-injectable GnRH Drugs Market Share Forecast by Country (2027-2032) Table 147. Latin America Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Latin America Non-injectable GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 149. Latin America Non-injectable GnRH Drugs Sales Market Share by Country (2021-2026) Table 150. Latin America Non-injectable GnRH Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 151. Latin America Non-injectable GnRH Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Non-injectable GnRH Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Non-injectable GnRH Drugs Market Share by Country (2021-2026) Table 155. Latin America Non-injectable GnRH Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Non-injectable GnRH Drugs Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Non-injectable GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Non-injectable GnRH Drugs Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Non-injectable GnRH Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 161. Middle East and Africa Non-injectable GnRH Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Non-injectable GnRH Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Non-injectable GnRH Drugs Market Share by Country (2021-2026) Table 165. Middle East and Africa Non-injectable GnRH Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Non-injectable GnRH Drugs Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Non-injectable GnRH Drugs Distributors List Table 170. Non-injectable GnRH Drugs Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Non-injectable GnRH Drugs Image Figure 2. Global Non-injectable GnRH Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-injectable GnRH Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-injectable GnRH Drugs Sales (2021-2032) & (K Units) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Nasal Spray Image Figure 8. Global Nasal Spray Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Non-injectable GnRH Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Non-injectable GnRH Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Non-injectable GnRH Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Non-injectable GnRH Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Non-injectable GnRH Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Non-injectable GnRH Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Non-injectable GnRH Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Non-injectable GnRH Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Non-injectable GnRH Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Non-injectable GnRH Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Non-injectable GnRH Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Non-injectable GnRH Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Non-injectable GnRH Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Menorrhagia Image Figure 26. Global Menorrhagia Sales YoY Growth (2021-2032) & (K Units) Figure 27. Central Precocious Puberty Image Figure 28. Global Central Precocious Puberty Sales YoY Growth (2021-2032) & (K Units) Figure 29. Uterine Fibroids Image Figure 30. Global Uterine Fibroids Sales YoY Growth (2021-2032) & (K Units) Figure 31. Endometriosis Image Figure 32. Global Endometriosis Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Non-injectable GnRH Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Non-injectable GnRH Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Non-injectable GnRH Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Non-injectable GnRH Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Non-injectable GnRH Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Non-injectable GnRH Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Non-injectable GnRH Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Non-injectable GnRH Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Non-injectable GnRH Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Non-injectable GnRH Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Non-injectable GnRH Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Non-injectable GnRH Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Non-injectable GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Non-injectable GnRH Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Non-injectable GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Non-injectable GnRH Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Non-injectable GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Non-injectable GnRH Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Non-injectable GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Non-injectable GnRH Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Non-injectable GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Non-injectable GnRH Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Non-injectable GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Non-injectable GnRH Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Non-injectable GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Non-injectable GnRH Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Non-injectable GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Non-injectable GnRH Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Non-injectable GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Non-injectable GnRH Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Non-injectable GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Non-injectable GnRH Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Non-injectable GnRH Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Non-injectable GnRH Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Nasal Spray
  • Others
Applications
  • Menorrhagia
  • Central Precocious Puberty
  • Uterine Fibroids
  • Endometriosis
  • Other
Companies covered
  • Sanofi
  • Pfizer
  • Abbvie
  • Sumitomo Pharma
  • ObsEva
  • Neon Healthcare
  • JW Pharmaceutical
  • Fuji Pharma
  • ASKA Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-injectable GnRH Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non-injectable GnRH Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non-injectable GnRH Drugs Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Nasal Spray
  8. 1.3.3 Others
  9. 1.4 Global Non-injectable GnRH Drugs Market Size by Type
  10. 1.4.1 Global Non-injectable GnRH Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Non-injectable GnRH Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Non-injectable GnRH Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Non-injectable GnRH Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Non-injectable GnRH Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Non-injectable GnRH Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Non-injectable GnRH Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Non-injectable GnRH Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non-injectable GnRH Drugs Industry Trends
  2. 2.2 Non-injectable GnRH Drugs Industry Drivers
  3. 2.3 Non-injectable GnRH Drugs Industry Opportunities and Challenges
  4. 2.4 Non-injectable GnRH Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non-injectable GnRH Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Non-injectable GnRH Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Non-injectable GnRH Drugs Price (2021-2026)
  4. 3.4 Global Non-injectable GnRH Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-injectable GnRH Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Non-injectable GnRH Drugs Company, Product Type & Application
  7. 3.7 Global Non-injectable GnRH Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-injectable GnRH Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-injectable GnRH Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-injectable GnRH Drugs Tier 1, Tier 2, and Tier 3
4 Non-injectable GnRH Drugs Regional Status and Outlook
  1. 4.1 Global Non-injectable GnRH Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non-injectable GnRH Drugs Historic Market Size by Region
  3. 4.2.1 Global Non-injectable GnRH Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non-injectable GnRH Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non-injectable GnRH Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non-injectable GnRH Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Non-injectable GnRH Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non-injectable GnRH Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non-injectable GnRH Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-injectable GnRH Drugs by Application
  1. 5.1 Non-injectable GnRH Drugs Market by Application
  2. 5.1.1 Menorrhagia
  3. 5.1.2 Central Precocious Puberty
  4. 5.1.3 Uterine Fibroids
  5. 5.1.4 Endometriosis
  6. 5.1.5 Other
  7. 5.2 Global Non-injectable GnRH Drugs Market Size by Application
  8. 5.2.1 Global Non-injectable GnRH Drugs Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Non-injectable GnRH Drugs Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Non-injectable GnRH Drugs Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Non-injectable GnRH Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Non-injectable GnRH Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Non-injectable GnRH Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Non-injectable GnRH Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Non-injectable GnRH Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Non-injectable GnRH Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Non-injectable GnRH Drugs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Abbvie
  14. 6.3.1 Abbvie Company Information
  15. 6.3.2 Abbvie Business Overview
  16. 6.3.3 Abbvie Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Abbvie Non-injectable GnRH Drugs Product Portfolio
  18. 6.3.5 Abbvie Recent Developments
  19. 6.4 Sumitomo Pharma
  20. 6.4.1 Sumitomo Pharma Company Information
  21. 6.4.2 Sumitomo Pharma Business Overview
  22. 6.4.3 Sumitomo Pharma Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sumitomo Pharma Non-injectable GnRH Drugs Product Portfolio
  24. 6.4.5 Sumitomo Pharma Recent Developments
  25. 6.5 ObsEva
  26. 6.5.1 ObsEva Company Information
  27. 6.5.2 ObsEva Business Overview
  28. 6.5.3 ObsEva Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ObsEva Non-injectable GnRH Drugs Product Portfolio
  30. 6.5.5 ObsEva Recent Developments
  31. 6.6 Neon Healthcare
  32. 6.6.1 Neon Healthcare Company Information
  33. 6.6.2 Neon Healthcare Business Overview
  34. 6.6.3 Neon Healthcare Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Neon Healthcare Non-injectable GnRH Drugs Product Portfolio
  36. 6.6.5 Neon Healthcare Recent Developments
  37. 6.7 JW Pharmaceutical
  38. 6.7.1 JW Pharmaceutical Company Information
  39. 6.7.2 JW Pharmaceutical Business Overview
  40. 6.7.3 JW Pharmaceutical Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 JW Pharmaceutical Non-injectable GnRH Drugs Product Portfolio
  42. 6.7.5 JW Pharmaceutical Recent Developments
  43. 6.8 Fuji Pharma
  44. 6.8.1 Fuji Pharma Company Information
  45. 6.8.2 Fuji Pharma Business Overview
  46. 6.8.3 Fuji Pharma Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Fuji Pharma Non-injectable GnRH Drugs Product Portfolio
  48. 6.8.5 Fuji Pharma Recent Developments
  49. 6.9 ASKA Pharmaceutical
  50. 6.9.1 ASKA Pharmaceutical Company Information
  51. 6.9.2 ASKA Pharmaceutical Business Overview
  52. 6.9.3 ASKA Pharmaceutical Non-injectable GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ASKA Pharmaceutical Non-injectable GnRH Drugs Product Portfolio
  54. 6.9.5 ASKA Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Non-injectable GnRH Drugs Sales by Country
  2. 7.1.1 North America Non-injectable GnRH Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non-injectable GnRH Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Non-injectable GnRH Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non-injectable GnRH Drugs Market Size by Country
  6. 7.2.1 North America Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non-injectable GnRH Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Non-injectable GnRH Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non-injectable GnRH Drugs Sales by Country
  2. 8.1.1 Europe Non-injectable GnRH Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non-injectable GnRH Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Non-injectable GnRH Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non-injectable GnRH Drugs Market Size by Country
  6. 8.2.1 Europe Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non-injectable GnRH Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non-injectable GnRH Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non-injectable GnRH Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Non-injectable GnRH Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non-injectable GnRH Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non-injectable GnRH Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non-injectable GnRH Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non-injectable GnRH Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non-injectable GnRH Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non-injectable GnRH Drugs Sales by Country
  2. 10.1.1 South America Non-injectable GnRH Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non-injectable GnRH Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Non-injectable GnRH Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non-injectable GnRH Drugs Market Size by Country
  6. 10.2.1 South America Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non-injectable GnRH Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Non-injectable GnRH Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non-injectable GnRH Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Non-injectable GnRH Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non-injectable GnRH Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non-injectable GnRH Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non-injectable GnRH Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Non-injectable GnRH Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non-injectable GnRH Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non-injectable GnRH Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non-injectable GnRH Drugs Value Chain Analysis
  2. 12.1.1 Non-injectable GnRH Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non-injectable GnRH Drugs Production Mode & Process
  7. 12.2 Non-injectable GnRH Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non-injectable GnRH Drugs Distributors
  10. 12.2.3 Non-injectable GnRH Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst